BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 26563859)

  • 1. Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study.
    Prati F; Romagnoli E; Burzotta F; Limbruno U; Gatto L; La Manna A; Versaci F; Marco V; Di Vito L; Imola F; Paoletti G; Trani C; Tamburino C; Tavazzi L; Mintz GS
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1297-305. PubMed ID: 26563859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome).
    Prati F; Romagnoli E; Gatto L; La Manna A; Burzotta F; Limbruno U; Versaci F; Fabbiocchi F; Di Giorgio A; Marco V; Ramazzotti V; Di Vito L; Trani C; Porto I; Boi A; Tavazzi L; Mintz GS
    Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term consequences of optical coherence tomography findings during percutaneous coronary intervention: the Centro Per La Lotta Contro L'infarto - Optimization Of Percutaneous Coronary Intervention (CLI-OPCI) LATE study.
    Prati F; Romagnoli E; La Manna A; Burzotta F; Gatto L; Marco V; Fineschi M; Fabbiocchi F; Versaci F; Trani C; Tamburino C; Alfonso F; Mintz GS
    EuroIntervention; 2018 Jul; 14(4):e443-e451. PubMed ID: 29633940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study.
    Prati F; Di Vito L; Biondi-Zoccai G; Occhipinti M; La Manna A; Tamburino C; Burzotta F; Trani C; Porto I; Ramazzotti V; Imola F; Manzoli A; Materia L; Cremonesi A; Albertucci M
    EuroIntervention; 2012 Nov; 8(7):823-9. PubMed ID: 23034247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of suboptimal stent deployment as assessed by optical coherence tomography: long-term results of the CLI-OPCI registry.
    Prati F; Romagnoli E; Biccirè FG; Burzotta F; La Manna A; Budassi S; Ramazzotti V; Albertucci M; Fabbiocchi F; Sticchi A; Trani C; Calligaris G; Fineschi M; Versaci F; Tamburino C; Ozaki Y; Alfonso F; Mintz GS
    EuroIntervention; 2022 Jun; 18(2):e150-e157. PubMed ID: 34825652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of residual acute stent malapposition in percutaneous coronary interventions.
    Romagnoli E; Gatto L; La Manna A; Burzotta F; Taglieri N; Saia F; Amico F; Marco V; Ramazzotti V; Di Giorgio A; Di Vito L; Boi A; Contarini M; Castriota F; Mintz GS; Prati F
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):566-575. PubMed ID: 28295990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of optical coherence tomography in identifying sub-optimal stent positioning and predicting major adverse cardiac events in a comparative study with angiography: a CLIO-OPCI II sub-study.
    Gatto L; Golino M; Marco V; La Manna A; Burzotta F; Fineschi M; Ruscica G; Di Giorgio A; Boi A; Romagnoli E; Albertucci M; Prati F
    Coron Artery Dis; 2018 Aug; 29(5):384-388. PubMed ID: 29697483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
    Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictors, morphological characteristics, and clinical outcomes of stent edge dissections detected by optical coherence tomography.
    Chamié D; Bezerra HG; Attizzani GF; Yamamoto H; Kanaya T; Stefano GT; Fujino Y; Mehanna E; Wang W; Abdul-Aziz A; Dias M; Simon DI; Costa MA
    JACC Cardiovasc Interv; 2013 Aug; 6(8):800-13. PubMed ID: 23871510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.
    Ielasi A; Takagi K; Latib A; Basavarajaiah S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2014 Mar; 83(4):530-8. PubMed ID: 23983065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of coronary artery stent edge dissections on long-term clinical outcome in patients with acute coronary syndrome: an optical coherence tomography study.
    Bouki KP; Sakkali E; Toutouzas K; Vlad D; Barmperis D; Phychari S; Riga M; Apostolou T; Stefanadis C
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):237-46. PubMed ID: 25620191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation.
    Won H; Shin DH; Kim BK; Mintz GS; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2013 Aug; 29(6):1255-63. PubMed ID: 23615849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.